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of	the	non‐Helicobacter pylori gastric microbiome in gastric carcinogenesis remains 
unclear. We evaluated the characteristics of the gastric microbiome and metagen‐
omic functions in patients with IM.
Methods: Participants were classified into six groups according to disease status (chronic 
superficial	gastritis	[CSG],	intestinal	metaplasia	[IM],	and	cancer)	and	H. pylori‐ infection 
status (H. pylori‐positive and H. pylori‐negative).	The	gastric	microbiome	was	analyzed	in	
mucosal	tissues	at	the	gastric	antrum	by	16S	rRNA	gene	sequencing.	Moreover,	we	as‐
sessed	the	metagenome	including	the	type	IV	secretion	system	(T4SS)	gene,	as	T4SS	pro‐
teins	are	essential	for	transferring	CagA	from	H. pylori‐ into the human gastric epithelium.
Results:	Among	the	138	included	patients,	48,	9,	23,	14,	12,	and	32	were	classified	
into the H. pylori‐negative	CSG,	H. pylori‐negative	 IM,	H. pylori‐negative	 cancer,	H. 
pylori‐positive	CSG,	H. pylori‐positive	IM,	and	H. pylori‐positive	cancer	groups,	respec‐
tively. Cyanobacteria were predominant in the H. pylori‐negative	CSG	 group	 com‐
pared to in the H. pylori‐negative IM and H. pylori‐negative cancer groups (H. 
pylori‐negative	CSG	vs	H. pylori‐negative IM vs H. pylori‐negative cancer: 14.0% vs 
4.2%	vs	0.04%,	P	<	0.001).	In	contrast,	Rhizobiales	were	commonly	observed	in	the	H. 
pylori‐negative IM group (H. pylori‐negative	CSG	vs	H. pylori‐negative IM vs H. pylori‐
negative	 cancer:	 1.9%	 vs	 15.4%	 vs	 2.8%,	 P	<	0.001).	 The	 relative	 abundance	 of	
Rhizobiales	increased	as	H. pylori‐infected stomachs progressed from gastritis to IM. 
In the H. pylori‐negative	IM	group,	genes	encoding	T4SS	were	prevalent	among	the	
metagenome.	Additionally,	after	H. pylori‐	eradication	therapy,	the	gastric	microbiome	
was similar to the microbiome observed after spontaneous clearance of H. pylori‐.
Conclusions:	The	relative	abundance	of	Rhizobiales	was	higher	 in	patients	with	H. 
pylori‐negative IM than in those with H. pylori‐negative	CSG	or	cancer.	Additionally,	
T4SS	genes	were	highly	observed	 in	 the	metagenome	of	patients	with	 IM.	Highly	
abundant	T4SS	proteins	in	these	patients	may	promote	gastric	carcinogenesis.
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1  | INTRODUC TION
There are several unsolved aspects of Helicobacter pylori	 ‐related	
gastric	 carcinogenesis.	 First,	 H. pylori‐ often disappears sponta‐
neously in elderly patients because of the progression of atrophic 
gastritis	and	intestinal	metaplasia	(IM),1 while gastric cancer typically 
develops in elderly individuals rather than in younger individuals.2 
Although	IM	has	been	suggested	as	a	precancerous	lesion	after	the	
clearance	of	H.	pylori,	it	is	unknown	whether	IM	itself	causes	gastric	
cancer	 development.	 Second,	H. pylori‐ eradication therapy alone 
cannot	 completely	 prevent	 gastric	 cancer,	 particularly	 in	 patients	
with	precancerous	lesions,	including	IM.3 These results indicate that 
specific changes that initiate gastric carcinogenesis occur in patients 
with IM.
Overgrowth of a bacterial species other than H. pylori‐ in patients 
with	 IM	must	be	considered,	as	many	human	diseases	are	affected	
by the microbiome.4	 Previous	 studies	 reported	 that	 nitrate‐	 and	
nitrite‐reducing	 bacteria	 were	 identified	 in	 the	 achlorhydric	 stom‐
ach.5,6	 Additionally,	 the	 metagenome	 derived	 from	 intragastric	
bacteria other than H. pylori‐ should be evaluated. The type IV se‐
cretion	 system	 (T4SS)	 gene	 is	 particularly	 important	 because	 T4SS	
proteins	are	essential	 for	 transferring	CagA	from	H. pylori‐ into the 
human gastric epithelium.9	 T4SS	 genes	 are	 present	 in	 various	 bac‐







Recently,	 there	have	been	several	attempts	 to	determine	 the	 fea‐
tures	 of	 the	 gastric	 microbiome	 using	 next‐generation	 sequencing.	
Previous studies demonstrated that the distribution of the gastric micro‐
biome differs between patients with gastric cancer and those without 
gastric cancer.12,13	Particularly,	Coker	et	al14 identified differences in bac‐
terial	interactions	across	stages	of	gastric	carcinogenesis.	However,	the	
metagenome of the stomach has not been evaluated.12,13	Additionally,	
previous studies mainly focused on the gastric microbiome in patients 
with	gastric	cancer	rather	than	on	precancerous	lesions,	such	as	IM.	To	




we evaluated the characteristics of the gastric microbiome and metage‐
nomic	functions	in	patients	with	IM.	We	further	analyzed	whether	there	
were differences in the gastric microbiome in patients with spontaneous 
clearance of H. pylori‐ and those with H. pylori‐ eradication via antibiotics.
2  | METHODS
2.1 | Study design
Asymptomatic	 volunteers	 or	 patients	 with	 dyspepsia	 who	 were	
scheduled for upper gastrointestinal endoscopy were recruited 
for	this	study.	Exclusion	criteria	were	as	follows:	(a)	patients	who	
took	 medications	 including	 proton‐pump	 inhibitors,	 H2 recep‐
tor	 antagonists,	 antacids,	 probiotics,	 mucosal	 protective	 agents,	




Because	H. pylori‐ is a predominant bacterial taxon in the gas‐
tric microbiome of patients with H. pylori‐	 infection,	patients	were	
classified according to the histology of the gastric mucosa as well 




and without H. pylori‐	 infection,	 (b)	group	B	(H. pylori‐negative	IM),	
patients with IM and without H. pylori‐	infection,	(c)	group	C	(H. py‐
lori‐negative	cancer),	patients	with	gastric	cancer	and	without	H. py‐
lori‐	infection,	(d)	group	D	(H. pylori‐positive	CSG),	patients	with	CSG	




resent patients with prior infection and spontaneous clearance of 
H.	pylori.
Microbial distribution was compared among the groups (H. pylo‐
ri‐negative	CSG,	H. pylori‐negative	 IM,	and	H. pylori‐negative	cancer)	
using	cladograms	and	principal	component	analysis	plots.	Linear	dis‐
criminant analyses were performed to identify significant bacterial 
taxa	in	each	group.	We	then	further	analyzed	metagenomic	functions	
using the phylogenetic investigation of communities by reconstruction 
of	unobserved	states	(PICRUSt)	method	based	on	16S	rRNA	gene	se‐
quences	to	identify	the	potential	roles	of	non‐H.	pylori	gastric	microbi‐
ome components in gastric carcinogenesis.
The study protocol was approved by the Institutional Review 
Board	 on	 Human	 Subjects	 Research	 and	 Ethics	 Committees	
Hanyang	 University	 Guri	 Hospital,	 Korea.	 All	 research	 was	 per‐
formed	in	accordance	with	relevant	guidelines	and	regulations.	All	
patients provided written informed consent before enrollment. The 
study was registered at the International Clinical Trials Registry 
Platform,	 no.	 KCT0001602	 (https://cris.nih.go.kr)	 on	 August	 25,	
2015.
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2.2 | Tissue sampling and serologic testing
For	microbiome	analysis,	four	pieces	of	gastric	mucosal	tissue	were	
obtained by endoscopic biopsy from the greater curvature side of 
the	mid‐antrum.	Next,	the	rapid	urease	test	was	performed	to	evalu‐
ate H. pylori‐ infection status. One additional piece of mucosal tis‐
sue from the gastric antrum was biopsied for histologic examination 
of	gastritis,	IM,	and	cancer.	All	biopsy	samples	were	obtained	from	
nearly	adjacent	sites	in	the	greater	curvature	side	of	the	mid‐antrum.




2.3 | H. pylori- eradication therapy
In the H. pylori‐positive	 CSG	 group,	 patients	 were	 administered	
H. pylori‐ eradication therapy with the standard triple regimen for 
2	weeks	(rabeprazole	20	mg,	amoxicillin	1	g,	clarithromycin	500	mg,	
twice	daily).	One	month	after	eradication	therapy,	four	pieces	of	gas‐
tric mucosal tissue in the greater curvature side of the antrum were 
endoscopically	biopsied	to	analyze	microbiome	changes	after	eradi‐
cation. H. pylori‐ eradication was confirmed by the13	C‐urea	breath	
test.	Patients	administered	H.	pylori	eradication	therapy	were	fur‐
ther classified into successful eradication and failed eradication 
groups	according	to	the	results	of	H.	pylori	eradication	therapy.
2.4 | Extraction of bacterial DNA
Extraction	of	bacterial	DNA	from	mucosal	biopsy	samples	was	per‐
formed as previously described.12	Briefly,	100	mg	of	frozen	gastric	mu‐
















2.5 | 16S rRNA gene sequencing and analysis
Extracted	 gDNA	 was	 amplified	 using	 the	 following	 primers	 tar‐
geting	 the	 V3	 to	 V4	 regions	 of	 the	 16S	 rRNA	 gene:	 forward,	 5′‐
TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGG 




Sequence	 data	were	 processed	 using	QIIME	 version	 1.9.0.15 Reads 
showing	 low	quality,	containing	 incorrect	primer	sequences,	or	con‐




estimation due to copy number variation.16 Taxonomic composition 
from the phylum to the species levels and bacterial diversity for each 
sample were evaluated based on 97% similarity with the GreenGenes 
database	(version	13.5),	using	QIIME.	Principal	component	analysis	of	
bacterial abundance was performed based on the Euclidean distance 
to compare the microbial communities of subgroups. Differential 
abundant features of relative abundance of bacterial taxa or metagen‐
omic	functions	were	identified	using	the	Linear	Discriminant	Analysis	
Effect	Size,	which	is	an	algorithm	for	high‐dimensional	biomarker	dis‐
covery and explanation that identifies genomic features by character‐
izing	differences	under	two	or	more	biological	conditions.17
DNA	sequences	obtained	from	this	metagenomic	project	were	
deposited	 in	 the	 National	 Center	 for	 Biotechnology	 Information	
(NCBI)	Short	Read	Archive	under	the	Accession	No.	SRP109017.
In patients with H. pylori‐	 infection,	 cagA positivity was de‐
termined	 by	 semi‐quantitative	 PCR	 using	 the	 following	 prim‐
ers18:	 forward,	 5′‐GATAACAGGCAAGCTTTTGAGG‐3′;	 reverse,	
5′‐CTGCAAAAGATTGTTTGGCAGA‐3′.
2.6 | Metagenome prediction
Functional	 composition	 of	 the	 microbiome	 was	 predicted	 using	
PICRUSt.19	 PICRUSt	 conducts	 evolutionary	 modeling	 to	 predict	 the	




2.7 | Download of sequence data
To	 improve	 the	 comparability	 and	 statistical	 power,	 microbiome	 se‐
quences	 in	 gastric	 cancer	 tissues	 were	 downloaded	 from	 the	 NCBI	
(https://www.ncbi.nlm.nih.gov)	 following	 literature	 review.12,13,20 
Inclusion	 criteria	 for	 microbiome	 sequences	 in	 the	 previous	 studies	
were	as	follows:	(a)	gastric	microbiome	derived	from	East	Asian	patients	
with	gastric	cancer	and	(b)	known	H. pylori‐ infection status. These se‐
quence	data	were	analyzed	in	the	same	manner	as	the	sequence	data.
2.8 | Statistical analysis
Continuous and categorical variables were described as the mean 
with	standard	deviation	and	number	with	proportion,	respectively.	In	
the linear discriminant analyses to detect the relative abundance of 







using	Galaxy,	 an	 open,	web‐based	 platform	 for	 computational	 bio‐
medical	research	(https://huttenhower.sph.harvard.edu/galaxy).
3  | RESULTS
3.1 | Baseline characteristics and microbiome reads
Table 1 shows the baseline patient characteristics and microbiome 
reads.	 Among	 patients	 with	 CSG	 or	 IM,	 48,	 9,	 14,	 and	 12	were	
classified into the H. pylori‐negative	CSG,	H. pylori‐negative	IM,	H. 
pylori‐positive	CSG,	and	H. pylori‐positive	IM	groups,	respectively,	
according	to	H.	pylori	 testing	and	histologic	examination	results.	
All	microbiome	 sequences	of	 patients	with	CSG	or	 IM	were	ob‐
tained	and	analyzed	in	our	institute.
We also enrolled one patient in the H. pylori‐negative cancer 




H. pylori‐negative	cancer,	 and	30	patients	with	H. pylori‐positive 




The	 relative	 abundance	of	 non‐H.	 pylori	 Proteobacteria	 increased	 in	
the H. pylori‐negative	CSG	group,	followed	by	the	H. pylori‐negative IM 
group and H. pylori‐negative	cancer	group.	 In	patients	with	H.	pylori,	
Proteobacteria	(which	mainly	consisted	of	H.	pylori)	decreased	in	the	H. 
pylori‐positive	CSG	group,	followed	by	the	H. pylori‐positive IM group 
and H. pylori‐positive cancer group.
To	compare	the	microbiome	other	than	H.	pylori	with	disease	sta‐
tus	(CSG	vs	IM	vs	cancer),	we	determined	the	relative	bacterial	abun‐
dance of the H. pylori‐negative groups by using cladograms (Figure	1). 
Characteristically,	the	relative	abundance	of	Cyanobacteria	was	high	
in the H. pylori‐negative	CSG	group	(14.0%)	and	relatively	low	in	the	
H. pylori‐negative	IM	group	(4.2%).	Cyanobacteria	were	rarely	found	
in the H. pylori‐negative	cancer	group	(0.04%).	 In	contrast,	 the	rela‐
tive	abundance	of	Rhizobiales	was	distinctly	high	in	the	H. pylori‐neg‐
ative	 IM	 group	 (15.4%)	 and	 very	 low	 in	 the	H. pylori‐negative	CSG	
and H. pylori‐negative	 cancer	 groups	 (1.9%	and	2.8%,	 respectively).	
Detailed data regarding relative bacterial abundance are presented in 
Appendix	1.
3.3 | Principal component analysis
The principal component analysis plot showed that the H. pylori‐
negative	 CSG	 group	was	 distinct	 from	 the	H. pylori‐positive	 CSG,	
H. pylori‐positive	IM,	and	H. pylori‐negative	IM	groups	(Figure	2).	A	
linear transition was identified in the H. pylori‐positive	CSG	group,	
TA B L E  1  Baseline	patient	characteristics	and	microbiome	reads	of	samples
Variable HP(−) CSG HP(−) IM HP(−) cancer HP(+) CSG HP(+) IM HP(+) cancer P‐value
N 48 9 23 14 12 32
Age,	y,	mean	±	SD 32.3	±	11.0 67.4	±	7.7 61.8	±	10.9a 31.4	±	8.8 60.9	±	13.4 54.1	±	12.5a <0.001




54.7	±	34.4 41.8	±	16.9 NA 99.2	±	56.4 64.0	±	32.4 NA 0.001
Pepsinogen	II,	ng/mL,	
mean	±	SD
12.0	±	9.7 11.4	±	4.8 NA 29.1	±	15.4 25.5	±	12.7 NA <0.001
Pepsinogen	I/II	ratio,	
mean	±	SD
4.9	±	1.5 4.4	±	2.3 4.7	±	2.1a 5.3	±	7.7 2.5	±	0.9 3.3	±	1.5a 0.156
Microbiome	reads,	mean	±	SD
Read count 9134	±	5767 4542	±	2983 1930	±	2103 22430	±	5881 14948	±	5931 49849	±	98572 0.003
OTU 292	±	150 152	±	101 81	±	59 131	±	58 179	±	99 261	±	364 0.001
Chao1 estimator 161.6	±	58.8 95.2	±	29.5 52.2	±	29.6 85.2	±	27.8 105.7	±	32.9 105.9	±	92.6 <0.001
Shannon's	diversity	
index
3.84	±	0.33 3.30	±	0.46 1.74	±	0.70 0.74	±	0.41 1.74	±	1.23 1.69	±	0.96 <0.001
Simpson's	diversity	
index




the study by Jo et al13. 
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followed by the H. pylori‐positive IM group and H. pylori‐negative IM 
group	as	the	relative	abundance	of	H.	pylori	decreased.
3.4 | Linear discriminant analysis for relative 
bacterial abundance
Figure	S2	shows	the	results	of	linear	discriminant	analysis	for	the	
relative bacterial abundance among H. pylori‐negative groups. 
In the H. pylori‐negative	 CSG	 group,	 the	 relative	 abundances	 of	
Firmicutes and Cyanobacteria were significantly higher com‐
pared	 to	 in	 other	 groups.	 The	 relative	 abundance	of	Rhizobiales	
was higher in the H. pylori‐negative IM group than in the other 
two	groups.	Various	bacterial	taxa	including	Xanthomonadaceae,	
Streptococcaceae,	Moraxellaceae,	 and	 Pseudomonadaceae	were	
increased in the H. pylori‐negative cancer group compared to their 
abundances in the H. pylori‐negative	 CSG	 and	H. pylori‐negative 
IM groups.
3.5 | Metagenomic function
Metagenomic	 analysis	 was	 performed	 using	 16S	 rRNA	 gene	 se‐
quencing	 data	 and	 the	 PICRUSt	method.	 Figure	 S3	 shows	 the	 re‐
sults of linear discriminant analysis for metagenomic function in the 
H. pylori‐negative	 groups.	 Among	 the	 various	 functions	 that	were	
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significantly	higher	in	each	group,	we	detected	three	genes,	K03199,	
K03201,	and	K03204,	which	encode	T4SS	proteins	VirB4,	VirB6,	and	
VirB9,	 respectively	 (Figure	 3).	 These	 genes	were	 detected	 at	 high	
rates in the H. pylori‐negative	CSG	group	compared	to	that	in	the	H. 
pylori‐negative	CSG	and	H. pylori‐negative	cancer	groups.	Although	
the gene VirD4	 (K03205)	 encoding	 a	 T4SS	 protein	 was	 the	 most	
common in the H. pylori‐negative	CSG	group,	it	was	also	commonly	
identified in the H. pylori‐negative IM group compared to in the H. 
pylori‐negative	 cancer	 group.	 Additionally,	 other	 genes	 encoding	
T4SS	protein	subunits,	including	K03197,	K03198,	K03200,	K03202,	
K03203,	K03195,	and	K03196,	were	generally	higher	in	the	H. pylori‐
negative IM group than in the H. pylori‐negative	CSG	and	H. pylori‐
negative	cancer	groups	(Figure	S4).
3.6 | Relationship between H. pylori and Rhizobiales
Figure	4	shows	the	relationship	in	the	relative	abundance	between	
H. pylori‐	 and	 other	 T4SS	 gene‐contributing	 bacteria	 (Rhizobiales	
and	Neisseriaceae)	 in	 the	H. pylori‐positive	 CSG,	H. pylori‐positive 
IM,	 and	 H. pylori‐negative IM groups. The relative abundance of 
Rhizobiales	and	Neisseriaceae	gradually	increased	as	the	abundance	
of H. pylori‐	decreased.	Several	samples,	such	as	numbers	23‐27	in	
Figure	 4,	 showed	 a	 relatively	 high	 abundance	 of	 Rhizobiales	 and	
Neisseriaceae	 with	 a	 concurrent	 level	 of	 H.	 pylori	 abundance.	 In	
sample	numbers	28‐35,	H. pylori‐	was	rarely	found,	while	Rhizobiales	
were commonly observed
3.7 | H. pylori eradication therapy in patients 
with CSG
Figure	 S5	 shows	 the	 relative	 bacterial	 abundance	 at	 the	 phylum	
level before and after H. pylori+ eradication therapy in patients 
with	 CSG.	 Before	 eradication	 therapy,	 the	 relative	 abundance	 of	
Proteobacteria	was	>90%	in	all	samples.	As	shown	in	the	cladograms	
(Figure	5),	the	relative	abundance	of	Helicobacter	was	93.3%,	while	
that	 of	 non‐H. pylori‐	 Proteobacteria	 was	 2.9%.	 After	 eradication	
therapy,	the	relative	abundance	of	Proteobacteria	decreased;	how‐
ever,	that	of	non‐H. pylori‐	Proteobacteria	 increased	(46.8%)	in	the	
successful eradication group. In contrast to the results in the suc‐
cessful	eradication	group,	the	relative	abundance	of	Proteobacteria	
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was similar between before and after eradication therapy in the 
failed eradication group.
The distribution of bacterial abundance in the successful erad‐
ication group was similar to that in the H. pylori‐negative IM group 
(Figure	5).	The	successful	eradication	group	showed	a	high	abundance	
of	 Rhizobiales	 (16.2%)	 and	 some	 Cyanobacteria	 (3.3%).	 Principal	
component analysis also revealed similar clustering between the suc‐
cessful eradication and H. pylori‐negative	IM	groups	(Figure	S6).	For	
quantitative	assessment	of	group	similarity,	the	Bray‐Curtis	distance	
between samples in the successful eradication and H. pylori‐negative 
IM	groups	was	plotted,	as	shown	in	Figure	S7.	Dissimilarity	was	even	
lower in samples between the successful eradication and H. pylo‐






In	 the	 present	 study,	 we	 identified	 differential	 bacterial	 taxa	 and	
metagenomics functions according to the histology of gastric mu‐
cosa.	In	the	stomach	of	patients	with	IM,	Rhizobiales	was	a	commonly	
identified	bacterial	taxon.	The	relative	abundance	of	Rhizobiales	in‐
creased as H. pylori‐infected stomachs progressed from gastritis to 
IM.	We	also	found	that	genes	encoding	T4SS	were	prevalent	in	the	
metagenome of patients with IM.
T4SS	 proteins	 typically	 consist	 of	 11	VirB	 proteins	 (VirB1‐11)	
and	 the	coupled	protein	 (VirD4).21 These proteins enable the se‐
cretion	 of	 CagA	 from	 the	 bacterial	 cytoplasm	 directly	 into	 the	





Neisseriaceae	 to	H.	pylori	 in	patients	with	 IM,	 facilitating	gastric	
carcinogenesis.
Numerous	 studies	 have	 shown	 that	 horizontal	 gene	 transfer	
may	occur	between	bacteria,	including	H. pylori‐.23,24	Particularly,	
genes from H. pylori‐ may be lost or gained during the progres‐
sion from atrophic gastritis to gastric adenocarcinoma in the same 
patient.24	Additionally,	several	plasticity	zones	are	present	in	the	
H.	 pylori	 genome	 and	 show	 high	 genetic	 variation.25 They gen‐
erally	 contain	 complete	 sets	 of	 genes	 required	 to	 produce	 T4SS	
protein,	as	well	as	genes	encoding	different	DNA	processing	pro‐
teins.24,26,27	A	complete	T4SS	plasticity	zone	cluster	 is	known	to	
be	a	virulence	 factor	 that	may	be	 important	 for	 the	colonization	
of H. pylori‐ and development of severe outcomes of infection 
with	 cagA‐positive	 strains.29	 Additionally,	 genes	 encoding	 T4SS	
proteins can be transferred by conjugation between Rhizobium 
radiobacter and Bartonella rattaustraliani.30	 Network	 analysis	 of	
gene sharing among Proteobacterial genomes also revealed higher 
horizontal	gene	transfer	rates	at	the	phylum	level	than	at	the	spe‐
cies level.31	 Although	 there	 is	 no	 direct	 evidence	 of	 horizontal	
gene transfer between H. pylori‐	and	Rhizobiales,	our	results	sug‐
gest	that	T4SS	gene	transfer	occurs	between	H. pylori‐ and other 
microbiome components.
One possible hypothesis based on our results is that gastric car‐
cinogenesis	 initiation	 requires	 H. pylori‐ and other bacteria such as 
Rhizobiales	and	Neisseriaceae.	From	this	perspective,	patients	with	H. 
pylori‐predominant	CSG	are	not	regarded	as	being	at	a	high	risk	for	gas‐
tric	 cancer.	However,	 as	H. pylori‐infected stomach tissue progressed 
from	gastritis	 to	 IM,	the	abundance	of	gastric	microbiome	other	than	
H. pylori‐,	including	Rhizobiales	and	Neisseriaceae,	increased.	Therefore,	
patients with progressed IM who exhibit abundance of H. pylori‐ and 
other	microbiome	may	have	a	high	risk	of	gastric	cancer	development.	
If	CagA	translocation	occurs	in	these	patients,	gastric	cancer	cannot	be	
prevented even if H. pylori‐ is eradicated.
Additionally,	we	 found	 that	 the	gastric	microbiome	 in	 the	 suc‐
cessful eradication group resembled that in the H. pylori‐negative 
IM	group,	which	 is	 regarded	as	a	high‐risk	group.	The	results	 indi‐
cate that the gastric microbiome composition did not depend on 
the cause of H. pylori‐ clearance (eradication by antibiotics vs spon‐
taneous	clearance	after	IM	progression).	However,	a	change	in	the	
Rhizobiales‐abundant	microbiome	 after	H. pylori‐ eradication ther‐
apy	does	not	reflect	an	increase	in	gastric	cancer	risk,	as	the	source	
of	CagA	has	been	removed	through	H. pylori‐	eradication.	Thus,	the	
risk‐lowering	effect	of	H. pylori‐ eradication therapy was related to 
H. pylori‐ eradication itself rather than changes in gastric microbiome 
components besides H. pylori‐.
Interestingly,	 Cyanobacteria	 were	 highly	 abundant	 in	 the	H. py‐
lori‐negative	 CSG	 group.	 The	 relative	 abundance	 of	 Cyanobacteria	
decreased in the H. pylori‐negative	 CSG	 group,	 followed	 by	 the	
H. pylori‐negative IM group and H. pylori‐negative cancer group. 
Cyanobacteria abundance was not recovered in patients with a his‐
tory of H. pylori‐	infection,	even	after	H. pylori‐ eradication. These find‐
ings	 indicate	 that	 the	Cyanobacteria‐abundant	microbiome	 exerts	 a	
protective effect against H. pylori‐	infection.	Several	previous	studies	
showed that polysaccharides derived from Cyanobacteria prevented 
H. pylori‐ attachment to the gastric mucosa.32,33 Considering both the 
potentially preventive effect of Cyanobacteria for H. pylori‐ infection 
and relatively low abundance of Cyanobacteria in H. pylori‐eradicated 
patients,	the	re‐infection	risk	of	H. pylori‐ should be considered for pa‐
tients administered eradication therapy.
Our study demonstrated that bacterial taxa that affect gastric 
carcinogenesis	according	to	our	next‐generation	sequencing	results.	
Previous	studies	did	not	 identify	Rhizobiales	as	a	bacteria	 that	con‐
tributes to gastric carcinogenesis.12,13 There are two main reasons for 
these	discrepant	results	between	studies.	First,	we	initially	analyzed	
the microbiome in H. pylori‐negative	groups	and	HP‐positive	groups	
individually.	Because	H. pylori‐ is the most abundant taxa in H. pylo‐
ri‐infected	stomachs,	differences	in	other	microbiome	species	may	not	
be detected if H. pylori‐positive and H. pylori‐negative groups are ana‐
lyzed	together.	After	identifying	Rhizobiales	and	Neisseriaceae	as	taxa	
that	potentially	contribute	to	gastric	carcinogenesis,	we	analyzed	the	
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model	 in	carcinogenesis,34 the abundance of various taxa increased 
in the H. pylori−negative	cancer	group,	including	Xanthomonadaceae,	
Streptococcaceae,	 Moraxellaceae,	 and	 Pseudomonadaceae,	 which	
may	be	a	result,	rather	than	a	cause,	of	cancer	development.
Although	 this	 is	 the	 first	 study	 involving	 16S	 rRNA	gene	 se‐
quencing	 analysis	 to	 propose	 bacteria	 that	 contribute	 to	 gastric	
carcinogenesis,	there	were	several	 limitations	to	our	study.	First,	
the	sample	size	was	relatively	small	in	several	groups	such	as	the	
H. pylori‐positive IM and H. pylori−negative	IM	groups.	Therefore,	
only the VirB4,	VirB6,	 and	VirB9	 encoding	 the	T4SS	protein	 sub‐
units showed significantly different abundances among groups. 
However,	other	T4SS	subunit	genes	 tended	to	 increase	 in	 the	H. 
pylori−negative IM group compared to in the H. pylori−negative 
CSG	 and	 H. pylori−negative	 cancer	 groups.	 Larger	 studies	 may	
confirm our results and identify additional metagenomic functions 
affecting	 gastric	 carcinogenesis.	 Second,	most	 sequence	 data	 in	
the	cancer	group	were	downloaded	from	NCBI,	although	all	sam‐
ples	in	patients	with	CSG	or	IM	were	obtained	from	our	institute.	
Different study settings and sample collections may result in bias. 
However,	our	study	mainly	focused	on	the	gastric	microbiome	in	
patients	with	 IM	compared	 to	 those	with	CSG,	 rather	 than	 can‐
cer.	 Additionally,	 12	 of	 52	 downloaded	 samples	were	 deposited	
by	 our	 group	 in	 the	NCBI	 in	 our	 previous	 study	 (SRP038955).12 
Another	 34	 samples	were	 collected	 from	 a	 geographically	 adja‐
cent	 hospital	 from	our	 institute	 (GSE61493).13	 Third,	we	did	 not	
analyze	negative	control	samples	such	as	PCR‐amplified	ultrapure	
water	without	 template	DNA.	Because	 contaminating	DNA	may	
impact the results obtained from samples containing a low micro‐
bial	biomass,	concurrent	sequencing	of	negative	control	samples	
is advised.35	 However,	 negative	 controls	 were	 not	 analyzed	 our	
study.	 Nevertheless,	 contamination	 may	 not	 have	 a	 significant	
impact	on	our	 results,	 as	 the	 intestinal	metaplasia	cannot	be	 re‐
garded	 as	 a	 low	microbial	 environment.	 Fourth,	 we	 did	 directly	
demonstrate	 that	 horizontal	 gene	 transfer	 occurred	 between	H. 
pylori‐	 and	other	bacteria	 including	Rhizobiales	 and	Niserriaceae	
in	 the	 current	 study.	 Although	we	 hypothesized	 that	 T4SS	 gene	
transfer occurs between H. pylori‐	and	other	bacteria,	horizontal	
gene	transfer	is	more	likely	to	occur	among	members	of	the	same	
class than among those of different classes. Experimental studies 
are needed to validate the hypothesis derived from this study.
Despite	these	limitations,	our	study	improves	the	understanding	of	




and	 Neisseriaceae,	 were	 highly	 abundant.	 Additionally,	 the	 gastric	
microbiome after H. pylori‐ eradication therapy was similar to that ob‐
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